UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 3, 2024

Accession Number:	0001104659-24-076396
Submission Type:	POS AM
CIK: 0001730430 Company Name: Kiniksa Pharmaceuticals International, plc File Number: 333-264751